Skip to main content
PMC home page
Gut logoLink to Gut
. 2005 Mar;54(Suppl 1):i27–i32. doi: 10.1136/gut.2004.041566

Are screening and surveillance for Barrett's oesophagus really worthwhile?

P Sharma, E Sidorenko
PMCID: PMC1867790  PMID: 15711005

Full Text

The Full Text of this article is available as a PDF (77.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buttar N. S., Wang K. K., Sebo T. J., Riehle D. M., Krishnadath K. K., Lutzke L. S., Anderson M. A., Petterson T. M., Burgart L. J. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001 Jun;120(7):1630–1639. doi: 10.1053/gast.2001.25111. [DOI] [PubMed] [Google Scholar]
  2. Cameron A. J., Zinsmeister A. R., Ballard D. J., Carney J. A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990 Oct;99(4):918–922. doi: 10.1016/0016-5085(90)90607-3. [DOI] [PubMed] [Google Scholar]
  3. Canto M. I., Setrakian S., Petras R. E., Blades E., Chak A., Sivak M. V., Jr Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 1996 Jul;44(1):1–7. doi: 10.1016/s0016-5107(96)70221-3. [DOI] [PubMed] [Google Scholar]
  4. Conio Massimo, Blanchi Sabrina, Lapertosa Gabriella, Ferraris Roberto, Sablich Renato, Marchi Santino, D'Onofrio Vittorio, Lacchin Teresa, Iaquinto Gaetano, Missale Guido. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol. 2003 Sep;98(9):1931–1939. doi: 10.1111/j.1572-0241.2003.07666.x. [DOI] [PubMed] [Google Scholar]
  5. Corley Douglas A., Levin Theodore R., Habel Laurel A., Weiss Noel S., Buffler Patricia A. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar;122(3):633–640. doi: 10.1053/gast.2002.31879. [DOI] [PubMed] [Google Scholar]
  6. Devesa S. S., Blot W. J., Fraumeni J. F., Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998 Nov 15;83(10):2049–2053. [PubMed] [Google Scholar]
  7. Drewitz D. J., Sampliner R. E., Garewal H. S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol. 1997 Feb;92(2):212–215. [PubMed] [Google Scholar]
  8. Falk G. W., Ours T. M., Richter J. E. Practice patterns for surveillance of Barrett's esophagus in the united states. Gastrointest Endosc. 2000 Aug;52(2):197–203. doi: 10.1067/mge.2000.107728. [DOI] [PubMed] [Google Scholar]
  9. Gerson Lauren B., Shetler Katerina, Triadafilopoulos George. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology. 2002 Aug;123(2):461–467. doi: 10.1053/gast.2002.34748. [DOI] [PubMed] [Google Scholar]
  10. Gopal Deepak V., Lieberman David A., Magaret Nathan, Fennerty M. Brian, Sampliner Richard E., Garewal Harinder S., Falk Gary W., Faigel Douglas O. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003 Aug;48(8):1537–1541. doi: 10.1023/a:1024715824149. [DOI] [PubMed] [Google Scholar]
  11. Gross C. P., Canto M. I., Hixson J., Powe N. R. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. Am J Gastroenterol. 1999 Dec;94(12):3440–3447. doi: 10.1111/j.1572-0241.1999.01606.x. [DOI] [PubMed] [Google Scholar]
  12. Inadomi John M., Sampliner Richard, Lagergren Jesper, Lieberman David, Fendrick A. Mark, Vakil Nimish. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med. 2003 Feb 4;138(3):176–186. doi: 10.7326/0003-4819-138-3-200302040-00009. [DOI] [PubMed] [Google Scholar]
  13. Lagergren J., Bergström R., Lindgren A., Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825–831. doi: 10.1056/NEJM199903183401101. [DOI] [PubMed] [Google Scholar]
  14. Lagergren J., Ye W., Bergström R., Nyrén O. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA. 2000 Aug 23;284(8):961–962. doi: 10.1001/jama.284.8.961. [DOI] [PubMed] [Google Scholar]
  15. Lieberman D. A., Oehlke M., Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol. 1997 Aug;92(8):1293–1297. [PubMed] [Google Scholar]
  16. Macdonald C. E., Wicks A. C., Playford R. J. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ. 2000 Nov 18;321(7271):1252–1255. doi: 10.1136/bmj.321.7271.1252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McKenna Barbara J., Appelman Henry D. Dysplasia can be a pain in the gut. Pathology. 2002 Dec;34(6):518–528. [PubMed] [Google Scholar]
  18. Nietert Paul J., Silverstein Marc D., Mokhashi Mahesh S., Kim Christopher Y., Glenn Tammy F., Marsi Vicki A., Hawes Robert H., Wallace Michael B. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc. 2003 Mar;57(3):311–318. doi: 10.1067/mge.2003.101. [DOI] [PubMed] [Google Scholar]
  19. Nilsson Magnus, Johnsen Roar, Ye Weimin, Hveem Kristian, Lagergren Jesper. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003 Jul 2;290(1):66–72. doi: 10.1001/jama.290.1.66. [DOI] [PubMed] [Google Scholar]
  20. O'Connor J. B., Falk G. W., Richter J. E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999 Aug;94(8):2037–2042. doi: 10.1111/j.1572-0241.1999.01275.x. [DOI] [PubMed] [Google Scholar]
  21. Provenzale D., Kemp J. A., Arora S., Wong J. B. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol. 1994 May;89(5):670–680. [PubMed] [Google Scholar]
  22. Provenzale D., Schmitt C., Wong J. B. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol. 1999 Aug;94(8):2043–2053. doi: 10.1111/j.1572-0241.1999.01276.x. [DOI] [PubMed] [Google Scholar]
  23. Reid B. J., Levine D. S., Longton G., Blount P. L., Rabinovitch P. S. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000 Jul;95(7):1669–1676. doi: 10.1111/j.1572-0241.2000.02196.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reid B. J., Prevo L. J., Galipeau P. C., Sanchez C. A., Longton G., Levine D. S., Blount P. L., Rabinovitch P. S. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol. 2001 Oct;96(10):2839–2848. doi: 10.1111/j.1572-0241.2001.04236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rex Douglas K., Cummings Oscar W., Shaw Michael, Cumings Mark D., Wong Roy K. H., Vasudeva Raj S., Dunne Donal, Rahmani Emad Y., Helper Debra J. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003 Dec;125(6):1670–1677. doi: 10.1053/j.gastro.2003.09.030. [DOI] [PubMed] [Google Scholar]
  26. Saeian Kia, Staff David M., Vasilopoulos Sotirios, Townsend William F., Almagro Urias A., Komorowski Richard A., Choi Hongyung, Shaker Reza. Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasia. Gastrointest Endosc. 2002 Oct;56(4):472–478. doi: 10.1067/mge.2002.128131. [DOI] [PubMed] [Google Scholar]
  27. Sampliner Richard E., Practice Parameters Committee of the American College of Gastroenterology Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002 Aug;97(8):1888–1895. doi: 10.1111/j.1572-0241.2002.05910.x. [DOI] [PubMed] [Google Scholar]
  28. Schnell T. G., Sontag S. J., Chejfec G., Aranha G., Metz A., O'Connell S., Seidel U. J., Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001 Jun;120(7):1607–1619. doi: 10.1053/gast.2001.25065. [DOI] [PubMed] [Google Scholar]
  29. Shaheen N. J., Crosby M. A., Bozymski E. M., Sandler R. S. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology. 2000 Aug;119(2):333–338. doi: 10.1053/gast.2000.9302. [DOI] [PubMed] [Google Scholar]
  30. Sharma P. Controversies in Barrett's esophagus: management of high grade dysplasia. Semin Gastrointest Dis. 2001 Jan;12(1):26–32. [PubMed] [Google Scholar]
  31. Sharma P., Weston A. P., Topalovski M., Cherian R., Bhattacharyya A., Sampliner R. E. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut. 2003 Jan;52(1):24–27. doi: 10.1136/gut.52.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smith A. M., Maxwell-Armstrong C. A., Welch N. T., Scholefield J. H. Surveillance for Barrett's oesophagus in the UK. Br J Surg. 1999 Feb;86(2):276–280. doi: 10.1046/j.1365-2168.1999.01015.x. [DOI] [PubMed] [Google Scholar]
  33. Soni A., Sampliner R. E., Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol. 2000 Aug;95(8):2086–2093. doi: 10.1111/j.1572-0241.2000.02173.x. [DOI] [PubMed] [Google Scholar]
  34. Sorbi D., Gostout C. J., Henry J., Lindor K. D. Unsedated small-caliber esophagogastroduodenoscopy (EGD) versus conventional EGD: a comparative study. Gastroenterology. 1999 Dec;117(6):1301–1307. doi: 10.1016/s0016-5085(99)70280-5. [DOI] [PubMed] [Google Scholar]
  35. Streitz J. M., Jr, Andrews C. W., Jr, Ellis F. H., Jr Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg. 1993 Mar;105(3):383–388. [PubMed] [Google Scholar]
  36. Weston A. P., Badr A. S., Hassanein R. S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol. 1999 Dec;94(12):3413–3419. doi: 10.1111/j.1572-0241.1999.01602.x. [DOI] [PubMed] [Google Scholar]
  37. Winters C., Jr, Spurling T. J., Chobanian S. J., Curtis D. J., Esposito R. L., Hacker J. F., 3rd, Johnson D. A., Cruess D. F., Cotelingam J. D., Gurney M. S. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987 Jan;92(1):118–124. [PubMed] [Google Scholar]
  38. Wright T. A., Gray M. R., Morris A. I., Gilmore I. T., Ellis A., Smart H. L., Myskow M., Nash J., Donnelly R. J., Kingsnorth A. N. Cost effectiveness of detecting Barrett's cancer. Gut. 1996 Oct;39(4):574–579. doi: 10.1136/gut.39.4.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van Sandick J. W., van Lanschot J. J., Kuiken B. W., Tytgat G. N., Offerhaus G. J., Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998 Aug;43(2):216–222. doi: 10.1136/gut.43.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. van der Burgh A., Dees J., Hop W. C., van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut. 1996 Jul;39(1):5–8. doi: 10.1136/gut.39.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES